4516 N Stock Overview
Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Nippon Shinyaku Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥468.31 |
| 52 Week High | JP¥468.31 |
| 52 Week Low | JP¥468.31 |
| Beta | -0.15 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -72.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4516 N | MX Pharmaceuticals | MX Market | |
|---|---|---|---|
| 7D | 0% | -2.2% | -0.9% |
| 1Y | n/a | -20.7% | -4.7% |
Return vs Industry: Insufficient data to determine how 4516 N performed against the MX Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 4516 N performed against the MX Market.
Price Volatility
| 4516 N volatility | |
|---|---|
| 4516 N Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in MX Market | 6.1% |
| 10% least volatile stocks in MX Market | 2.6% |
Stable Share Price: 4516 N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 4516 N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1911 | 2,213 | Toru Nakai | www.nippon-shinyaku.co.jp |
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. Its Pharmaceuticals Business segment offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases.
Nippon Shinyaku Co., Ltd. Fundamentals Summary
| 4516 N fundamental statistics | |
|---|---|
| Market cap | Mex$25.42b |
| Earnings (TTM) | Mex$2.86b |
| Revenue (TTM) | Mex$16.42b |
9.0x
P/E Ratio1.6x
P/S RatioIs 4516 N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4516 N income statement (TTM) | |
|---|---|
| Revenue | JP¥148.26b |
| Cost of Revenue | JP¥50.23b |
| Gross Profit | JP¥98.02b |
| Other Expenses | JP¥72.17b |
| Earnings | JP¥25.85b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 07, 2024
| Earnings per share (EPS) | 383.82 |
| Gross Margin | 66.12% |
| Net Profit Margin | 17.44% |
| Debt/Equity Ratio | 0% |
How did 4516 N perform over the long term?
See historical performance and comparison